Zafar Saied Saify
University of Karachi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zafar Saied Saify.
Natural Product Research | 2011
Zafar Saied Saify; Mehrun Nisa; Kaniz Fizza Azhar; M. Kamran Azim; Huma Rasheed; Nousheen Mushtaq; M. Arshad Arain; Shazia Haider; Manawar Khanum; Waseem Ahmed
Piperidine derivatives are reported to exhibit a variety of pharmacological activities. In this article, synthesis and aspartic protease inhibitory activity of three nitrophenacyl derivatives of N-methyl-4-hydroxy piperidine are reported. Enzyme assays showed that the attachment of a nitro group in the benzene ring plays an important role in the inhibition of plasmepsin-II of Plasmodium falciparum. The compound 1-methyl-1-(4’-nitrophenacyl)-4-hydroxypiperidinium bromide (3), consisting of a nitro group at the para position, was the most active at the concentration of 1.0 µM. The activity of the compounds was evaluated through the observed orientation and diagrammatic representation of nitrophenacyl derivatives of 4-hydroxy piperidine.
International Journal of Biochemistry Research and Review | 2014
Zafar Saied Saify; Nighat Sultana; Nousheen Mushtaq; Nazia Zaheer Ul Hasan
As a part of our program to discover novel analoges of (1H-pyrrolo [2,3-b] pyridine) 7azaindole having useful biological activities, a variety of 7-azaindole analogs 1-9 with variable substituents on phenyl ring of phenacyl moiety were synthesized and evaluated for their AChE, BChE and antiglycation Inhibitory potential. Compounds 2-5 were found to Original Research Article International Journal of Biochemistry Research & Review, 4(6): 624-643, 2014 625 be AChE inhibitors with IC50 1.34 μM, 11.60 μM, 0.96 μM and 0.97 μM respectively, while compounds 2-5 were also found to be BChE inhibitors with IC50 1.25 μM, 3.93 μM, IC50 9.18μM and 10.20μM respectively. Compounds 2 (IC50 = 1.25±0.019uM) and 3 (IC50 = 3.93±0.36uM), showed potent BChE inhibitory potential than standard Galantamine (IC50 = 8.51±0.02uM). Besides this, compounds 2-9 were evaluated for glycation inhibition activity. Compound 5 (IC50 values 120.6+0.2uM) showed potent antiglycation potential than standard rutin (IC50=294.50+1.5uM). The size of the substituent, electron donating or withdrawing effect of substituents as well as the position of substituent on phenyl effects the activity.
Journal of Developing Drugs | 2017
Sumaira Ansari; Sadia Arif; Nousheen Mushtaq; Ahsaan Ahmed; Shamim Akhtar; Rabya Munawar; Huma Naseem; Sadia Meer; Zafar Saied Saify; Arif M; Qurratul ain Leghari
In present study, some 4-piperidinopiperidine (PP) and 4-amino methylpiperidine (AMP) derivatives (PP1-3 and AMP4-9) have been synthesized to explore their analgesic potential. Activity of compounds evaluated by in-vivo thermal (tail immersion) method produced significant analgesia at different doses. Docking results explained good binding affinity of synthesized derivatives and potential interaction of all compounds with mu-opioid receptor. The pharmacophoric model of synthesized compounds showed possible structural features required for analgesic activity when compared with standards (Fentanyl, Morphine, Pethidine). Among all PP1, AMP5 and AMP6 emerged out as potent analgesic agents. Graphical abstract
journal of applied pharmaceutical science | 2015
Kiran Rafiq; Muhammad Bilal Azmi; Zafar Saied Saify; Waqasuddin Khan; Irfan Ashraf; Najia Rahim; Greesh Kumar; Naureen Baloch
Kiran Rafiq, Muhammad Bilal Azmi, Zafar Saied Saify, Waqasuddin Khan, Irfan Ashraf , Najia Rahim, Greesh Kumar, Naureen Baloch Jinnah Sindh Medical University, Karachi, Pakistan. Quality Enhancement Cell, Dow University of Health Sciences, Karachi, Pakistan. H.E.J. Research Institute of Chemistry, International Centre for Chemical & Biological Sciences, University of Karachi, Karachi Pakistan. Jamil-ur-Rahman Center for Genome Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan. 5 Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan.
Pakistan Journal of Pharmaceutical Sciences | 2001
Zafar Saied Saify; Arif M; Shamim Akhtar; Nousheen Mushtaq; Mazhar F
Pakistan Journal of Pharmaceutical Sciences | 2003
Zafar Saied Saify; Ahmed F; Shamim Akhtar; Siddiqui S; Arif M; Hussain Sa; Nousheen Mushtaq
Bioorganic & Medicinal Chemistry Letters | 2012
Zafar Saied Saify; M. Kamran Azim; Waseem Ahmad; Mehrun Nisa; Daniel E. Goldberg; Shaheen A. Hussain; Shamim Akhtar; Arfa Akram; Arshad Arayne; Anna Oksman; Ishtiaq A. Khan
Pakistan Journal of Pharmaceutical Sciences | 1999
Zafar Saied Saify; Nousheen Mushtaq; Noor F; Takween S; Arif M
Pakistan Journal of Pharmaceutical Sciences | 2008
Nousheen Mushtaq; Zafar Saied Saify; Noor F; Takween S; Shamim Akhtar; Arif M; Khalid Mohammed Khan
Pakistan Journal of Pharmaceutical Sciences | 2005
Shamim Akhtar; Zafar Saied Saify; Arif M; Nousheen Mushtaq; Haleem Dj